Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell …

F Li, IAM Aljahdali, R Zhang, KL Nastiuk… - Journal of Experimental …, 2021 - Springer
The incidence of renal cell carcinoma (RCC) is increasing worldwide with an approximate
20% mortality rate. The challenge in RCC is the therapy-resistance. Cancer resistance to …

Stress-induced Epstein-Barr virus reactivation

DG Sausen, MS Bhutta, ES Gallo, H Dahari… - Biomolecules, 2021 - mdpi.com
Epstein-Barr virus (EBV) is typically found in a latent, asymptomatic state in
immunocompetent individuals. Perturbations of the host immune system can stimulate viral …

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis

T Zhang, C Yin, A Fedorov, L Qiao, H Bao… - Nature, 2022 - nature.com
Only a small proportion of patients with cancer show lasting responses to immune
checkpoint blockade (ICB)-based monotherapies. The RNA-editing enzyme ADAR1 is an …

MYC multimers shield stalled replication forks from RNA polymerase

D Solvie, A Baluapuri, L Uhl, D Fleischhauer, T Endres… - Nature, 2022 - nature.com
Oncoproteins of the MYC family drive the development of numerous human tumours. In
unperturbed cells, MYC proteins bind to nearly all active promoters and control transcription …

SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes

Y Xie, M Sahin, S Sinha, Y Wang, AM Nargund, Y Lyu… - Nature cancer, 2022 - nature.com
SETD2 is a histone H3 lysine 36 (H3K36) trimethyltransferase that is mutated with high
prevalence (13%) in clear cell renal cell carcinoma (ccRCC). Genomic profiling of primary …

Structure and function of the histone chaperone FACT–Resolving FACTual issues

K Gurova, HW Chang, ME Valieva, P Sandlesh… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Abstract FAcilitates Chromatin Transcription (FACT) has been considered essential for
transcription through chromatin mostly based on cell-free experiments. However, FACT …

[HTML][HTML] Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory

X Yuan, JA Seneviratne, S Du, Y Xu, Y Chen, Q Jin… - Cell Reports, 2022 - cell.com
Peripheral neuroblastic tumors (PNTs) represent a spectrum of neural-crest-derived tumors,
including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Malignant cells in …

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

LD Gamble, S Purgato, J Murray, L Xiao… - Science Translational …, 2019 - science.org
Amplification of the MYCN oncogene is associated with an aggressive phenotype and poor
outcome in childhood neuroblastoma. Polyamines are highly regulated essential cations …

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

Z Nagy, JA Seneviratne, M Kanikevich… - Nature …, 2021 - nature.com
To achieve the very high oncoprotein levels required to drive the malignant state cancer
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …

MYC controls the Epstein-Barr virus lytic switch

R Guo, C Jiang, Y Zhang, A Govande, SJ Trudeau… - Molecular cell, 2020 - cell.com
Epstein-Barr virus (EBV) is associated with multiple human malignancies. To evade immune
detection, EBV switches between latent and lytic programs. How viral latency is maintained …